Fight COVID-19 with VCO

In two clinical trials conducted by the Department of Science and Technology’s Food and Nutrition Research Institute (DOST-FNRI), virgin coconut oil (VCO) was observed to help ease mild to moderate COVID-19 symptoms among patients who received it as dietary supplement.

Whether mixed with food or consumed directly, VCO was seen to aid patients’ recovery from fever, cough, colds, body ache, and headache. Some patients who had meals mixed with VCO even showed diminishing symptoms as early as Day 2. By Day 18, most of the patients in the VCO Group were completely symptoms-free.

In addition to this positive development, researchers also noted that the mean C-Reactive Protein (CRP) levels among patients who received VCO normalized to 5 milligrams per liter of less, which signifies recovery, as early as Day 14. The CRP is a marker used to monitor inflammation or infection.

However, the DOST-FNRI clarified that VCO is not a COVID-19 cure but can be used as a supplement to other drugs such as antivirals and antibiotics.

“In conclusion, VCO can be an effective adjunct therapy in managing COVID-19 signs and symptoms, whether mixed in nutritious meals or taken separately,” DOST Secretary Fortunato T. dela Pe?a said. He also added that the result of the studies could be beneficial to the Philippine coconut industry and related enterprises.

The VCO used in the clinal trials were strictly analyzed by the Laboratory Services Division of the Philippine Coconut Authority (PCA) to ensure the product’s quality and compliance to Philippine National Standards (PNS).

Oleo-Fats is proud to announce that our VCO is FDA and PNS compliant. With these recent studies, we feel more purposeful in knowing that our product can help also fight COVID-19.